<?xml version="1.0" encoding="UTF-8"?>
<p>With regard to cytoreductive MIAT, a single retrospective study evaluating whole-gland cryotherapy in 23 men with a favourable response to 6-month ADT (PSA &lt;1.0 ng/mL), &lt;/=cT3 a disease, and limited bony metastasis, reported a 10-month survival advantage when compared with a matched cohort with ADT alone (35 months vs 25 months; HR 0.21 (95% CI 0.09 to 0.45); p=0.0027).
 <xref rid="R53" ref-type="bibr">53</xref>
</p>
